Mechanism of pain induced by radiocontrast media.
In lightly-anesthetized dogs, ionic or non-ionic RCM (Iotalamato and iohexol, respectively) when injected by intracarotid route (i.c.), elicit a pain response comparable to that caused by bradykinin (BK) or capsaicin (CAP). This response, which is characterized by vocalization, hyperpnea, bradycardia and neck muscle contraction, was dose dependent and related to the osmolarity of the RCM. In the present study we observed that indomethacin did not interfere with CAP and RCM-induced pain at dose (2 mg/kg i.c.) that reduced BK-elicited responses. In contrast, Ruthenium Red (RR), in dose (1 mg/kg i.c.) that reduced CAP and/or RCM-induced effects did not affect BK-induced phenomena. We also verified that L-NAME (50 mg/kg i.c.) reduced the BK-, but not the CAP- and/or RCM-induced pain responses which suggests that an L-arginine-derived NO or related compound is involved in BK activation of perivascular nociceptors. Indeed, we found that i.c. injection of 20 mg of S-nitrosocysteine, a putative EDRF, caused BK-like responses. On the other hand, RCM and CAP appear to activate the same RR sensitive ionic channels of primary afferent endings. Therefore, RR-analogues could constitute a novel approach to minimizing or eventually abolishing the RCM side effects.
D000818:Animals; D001920:Bradykinin / Q000502:physiology; D003287:Contrast Media / Q000633:toxicity*; D004285:Dogs; D005260:Female; D007472:Iohexol / Q000633:toxicity*; D007483:Iothalamic Acid / Q000633:toxicity*; D008297:Male; D010146:Pain / Q000139:chemically induced*; D012430:Ruthenium Red / Q000494:pharmacology
D003287:Contrast Media; D012430:Ruthenium Red; D007483:Iothalamic Acid; D007472:Iohexol; D001920:Bradykinin